During the past decade, Hospital Carlos Van Buren conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 6 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Carlos Van Buren" #1 sponsor was "Universidad de Valparaiso" with 4 trials, followed by "ETOP IBCSG Partners Foundation" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Galapagos NV" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Carlos Van Buren" #1 collaborator was "Hospital Carlos Van Buren" with 3 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Centro de Informática e Investigación Clínica (CIIC)" with 1 trials as a collaborator, "Children's National Research Institute" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Carlos Van Buren" are "Breast Cancer" (2 trials), "COVID-19" (2 trials), "Acute Diarrheal Disease" (1 trials), "Aneurysmal Subarachnoid Hemorrhage" (1 trials) and "Asthma" (1 trials). Many other conditions were trialed in "Hospital Carlos Van Buren" in a lesser frequency.

Most popular intervention types in "Hospital Carlos Van Buren" are "Drug" (12 trials), "Procedure" (3 trials), "Biological" (2 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Amniotic Membrane Dressing" (1 trials), "Analgesia based sedation in ICU patients" (1 trials), "Astegolimab" (1 trials) and "BI 764198" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Carlos Van Buren" are 16 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Carlos Van Buren". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Hospital Carlos Van Buren, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Carlos Van Buren, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".